Harvest One announced it has expanded its product portfolio with the launch of CBD oil through its Satipharm subsidiary.
The health, wellness, and lifestyle products supplier says bricks and mortar distribution will follow with major retailers throughout Europe.
The new European oils programme launched with a Lemon & Lime flavoured CBD oil and Satipharm expects to expand this programme with more varieties in the coming months.
Satipharm CBD oils join the existing CBD Gelpell capsules, already available across Europe online and in 1,800 stores across the UK and Ireland.
Satipharm’s products in Europe are EU GMP-certified
The Satipharm Lemon & Lime CBD oil was specifically formulated to address three major concerns from consumers, which are taste, GMP certification, and reliable dosage.
“Product innovation is essential to building our brands ,” said Grant Froese, CEO of Harvest One.
“Our new CBD oil illustrates continued movement by Harvest One towards our strategy of building health, wellness, and self-care brands around the world.
“Customers can have the same confidence in new Satipharm CBD oils as they do in our existing Satipharm CBD Gelpell already on the market across Europe.”
In March Brightfield Group, a market intelligence firm for the legal CBD and cannabis industries, released a report estimating that the European CBD market will boom over the next four years.
The market was estimated at $318 million in 2018 and is expected to grow over 400 percent through 2023.